Doc. No.: INS/GDL/001-(Annexes)
PQDx 0181-031-00
WHO PQ Public Report
March/2017, version 3.0
Lancet Planet Health 2017 Published Online November 6, 2017 http://dx.doi.org/10.1016/S2542-5196(17)30141-9
Establishing trauma referral pathways to provide urgent life-saving assistance for displaced populations and civilians remaining in Ar-Raqqa.
In July 2017, a WHO team comprising an external trauma care specialist and two WHO staff members visited the governorates of Ar-Raqqa and neighbouring Al-Ha...sakeh to assess the situation
more
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...ted. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low-
income countries alike. Now there is a divide between those countries where, because of intellectual
property barriers, prices have remained (very) high and other countries where generics are, or can be,
available at much lower prices. The result is a dual market
more
UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME
Practical Guidance for collaborative interventions
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
Evaluation Report
Evaluation Office
AIDS Behav (2017) 21:S23–S33 DOI 10.1007/s10461-016-1670-9
Case Study on Improving HIV Testing and Services for Children Orphaned or made Vulnerable by HIV (OVC)